Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD

BACKGROUND: Tumor necrosis factor-alpha (TNF-α) agonists revolutionized therapeutic algorithms in inflammatory bowel disease (IBD) management. However, approximately every third IBD patient does not respond to this therapy in the long term, which delays efficient control of the intestinal inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales: Coufal, Stepan, Kverka, Miloslav, Kreisinger, Jakub, Thon, Tomas, Rob, Filip, Kolar, Martin, Reiss, Zuzana, Schierova, Dagmar, Kostovcikova, Klara, Roubalova, Radka, Bajer, Lukas, Jackova, Zuzana, Mihula, Martin, Drastich, Pavel, Tresnak Hercogova, Jana, Novakova, Michaela, Vasatko, Martin, Lukas, Milan, Tlaskalova-Hogenova, Helena, Jiraskova Zakostelska, Zuzana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299888/
https://www.ncbi.nlm.nih.gov/pubmed/37383609
http://dx.doi.org/10.1155/2023/1535484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299888/
https://www.ncbi.nlm.nih.gov/pubmed/37383609
http://dx.doi.org/10.1155/2023/1535484

Ejemplares similares